ATE300315T1 - Verfahren zur festsetzung der optimalen strahlungsdosis zur strahlentherapie von krankheiten - Google Patents

Verfahren zur festsetzung der optimalen strahlungsdosis zur strahlentherapie von krankheiten

Info

Publication number
ATE300315T1
ATE300315T1 AT96916440T AT96916440T ATE300315T1 AT E300315 T1 ATE300315 T1 AT E300315T1 AT 96916440 T AT96916440 T AT 96916440T AT 96916440 T AT96916440 T AT 96916440T AT E300315 T1 ATE300315 T1 AT E300315T1
Authority
AT
Austria
Prior art keywords
determining
patient
centigray
log
administered
Prior art date
Application number
AT96916440T
Other languages
English (en)
Inventor
Richard L Wahl
Kenneth R Zasadny
Original Assignee
Univ Michigan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27411821&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE300315(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Michigan filed Critical Univ Michigan
Application granted granted Critical
Publication of ATE300315T1 publication Critical patent/ATE300315T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/103—Treatment planning systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Radiation-Therapy Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nuclear Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measurement Of Radiation (AREA)
AT96916440T 1995-05-04 1996-05-03 Verfahren zur festsetzung der optimalen strahlungsdosis zur strahlentherapie von krankheiten ATE300315T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US43367495A 1995-05-04 1995-05-04
US08/538,095 US6022521A (en) 1995-05-04 1995-10-02 Method of establishing the optimal radiation dose for radiopharmaceutical treatment of disease
US08/584,646 US6251362B1 (en) 1995-05-04 1996-01-11 Method of establishing the optimal radiation dose
PCT/US1996/006240 WO1996034632A1 (en) 1995-05-04 1996-05-03 Method of establishing the optimal radiation dose for radiopharmaceutical treatment of disease

Publications (1)

Publication Number Publication Date
ATE300315T1 true ATE300315T1 (de) 2005-08-15

Family

ID=27411821

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96916440T ATE300315T1 (de) 1995-05-04 1996-05-03 Verfahren zur festsetzung der optimalen strahlungsdosis zur strahlentherapie von krankheiten

Country Status (10)

Country Link
US (2) US6022521A (de)
EP (2) EP1666072A1 (de)
JP (1) JP4099227B2 (de)
AT (1) ATE300315T1 (de)
AU (1) AU723255B2 (de)
CA (1) CA2219999A1 (de)
DE (1) DE69634981T2 (de)
DK (1) DK0827411T3 (de)
ES (1) ES2249781T3 (de)
WO (1) WO1996034632A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ508674A (en) * 1998-06-04 2003-09-26 Univ Michigan A method for determining patient-specific dosimetry of a radippharmaceutical
DE20112718U1 (de) * 2001-08-01 2001-12-20 TRW Automotive Safety Systems GmbH & Co. KG, 63743 Aschaffenburg Fahrzeuglenkrad
DE60334364D1 (de) 2002-02-21 2010-11-11 Univ California Behandlungsverfahren unter verwendung von anti-cd22-antikörpern
US7465542B2 (en) * 2002-10-15 2008-12-16 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for determining risk of treatment toxicity
WO2007008232A2 (en) * 2004-09-03 2007-01-18 Board Of Regents, The University Of Texas System Locoregional internal radionuclide ablation of abnormal tissues.
US20060127311A1 (en) * 2004-11-17 2006-06-15 Duke University Radiation dosimetry and blocking antibodies and methods and uses therefor in the treatment of cancer
EP1998799B8 (de) 2006-03-06 2014-03-05 Medlmmune, LLC Humanisierte anti-cd22-antikörper und ihre verwendung für die behandlung von krebs, transplantationen und autoimmunerkrankungen
WO2007103469A2 (en) 2006-03-06 2007-09-13 Aeres Biomedical Ltd. Humanized anti-cd22 antibodies and their use in treatment of oncology, transplantation and autoimmune disease
WO2008079569A2 (en) 2006-11-21 2008-07-03 The Johns Hopkins University System and method for determining amount of radioactive material to administer to a patient
GB0818490D0 (en) * 2008-10-09 2008-11-12 Siemens Medical Solutions Post injection interval time correction of SUV in static PET scans
US9757084B2 (en) * 2011-12-22 2017-09-12 The Johns Hopkins University Method and system for administering radiopharmaceutical therapy (RPT)
JP5801850B2 (ja) * 2013-06-27 2015-10-28 日本メジフィジックス株式会社 核医学画像データの定量化
CN108398714B (zh) * 2017-02-08 2023-05-12 中国辐射防护研究院 一种用于内照射全身计数器校准模型的参数获取方法
JP6530128B1 (ja) * 2018-08-27 2019-06-12 日本メジフィジックス株式会社 被ばく線量管理装置、被ばく線量管理方法、およびプログラム
CN110559000B (zh) * 2019-08-14 2024-07-26 上海联影医疗科技股份有限公司 药物注射剂量检测方法、装置、存储介质及计算机设备
CN112221023B (zh) * 2020-09-27 2023-12-15 中国辐射防护研究院 一种放射性药物的剂量评估系统及方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4831122A (en) * 1986-01-09 1989-05-16 Regents Of The University Of Minnesota Radioimmunotoxins
US5034223A (en) 1986-10-09 1991-07-23 Neorx Corporation Methods for improved targeting of antibody, antibody fragments, hormones and other targeting agents, and conjugates thereof
US5342926A (en) * 1993-06-08 1994-08-30 The Regents Of The University Of California Analogs of cytochalasin B as radiopharmaceuticals for nuclear imaging of trans-membrane glucose transport
EP0757559A4 (de) * 1994-04-29 1999-06-23 Molecular Medicine Center Zusammensetzung zur verabreichung von toxischen radioisotopen in den zellkern und ihre verwendung
JP3122319B2 (ja) * 1994-05-02 2001-01-09 アソシエーティド ユニバーシティーズ，インコーポレイティド 錫−１１７ｍ−含有放射性治療剤

Also Published As

Publication number Publication date
AU723255B2 (en) 2000-08-24
DE69634981T2 (de) 2006-04-20
DK0827411T3 (da) 2005-10-24
EP1666072A1 (de) 2006-06-07
EP0827411B1 (de) 2005-07-27
DE69634981D1 (de) 2005-09-01
WO1996034632A1 (en) 1996-11-07
JPH11505450A (ja) 1999-05-21
JP4099227B2 (ja) 2008-06-11
ES2249781T3 (es) 2006-04-01
CA2219999A1 (en) 1996-11-07
EP0827411A1 (de) 1998-03-11
US6022521A (en) 2000-02-08
US6251362B1 (en) 2001-06-26
EP0827411A4 (de) 2000-04-05
AU5918796A (en) 1996-11-21

Similar Documents

Publication Publication Date Title
DE69634981D1 (de) Verfahren zur festsetzung der optimalen strahlungsdosis zur strahlentherapie von krankheiten
Henggeler et al. Multisystemic Therapy Adherence Measure
PL309033A1 (en) Method of activating photosensibilisers
NZ509668A (en) Method for preparing a radiation therapy plan
HUT62798A (en) Process for producing pharmaceutical composition with slimming activity
EP0358709A4 (de) Behandlung von diabetes durch kombinierte insulinformen.
ES2060941T3 (es) Uso de nicotina para la fabricacion de un estuche para el tratamiento de condiciones susceptibles de dicho tratamiento.
ATE125721T1 (de) Verfahren und vorrichtung zur aktiven physiotherapie von patienten mit knochenerkrankungen.
Teicher et al. Effects of dose and scheduling on growth delay of the Lewis lung carcinoma produced by the perfluorochemical emulsion, Fluosol-DA®
Ritschel et al. Pharmacokinetics of papaverine in man
Ryan et al. The role of sleep in electrosleep therapy for anxiety.
Herz et al. Development of tolerance to the antinociceptive effect of morphine after intraventricular injection
Haustermans et al. Is pulsed dose rate more damaging to spinal cord of rats than continuous low dose rate?
Olivares et al. Increased myocardial pyrimidine nucleotide synthesis in isoproterenol-induced cardiac hypertrophy in rats
Masse Cells at risk.
Bigler Dosimetry for evaluation of the biologic effects of radiation treatment using internally deposited radionuclides and labeled compounds
SU1705855A1 (ru) Способ моделировани гематогенных метастазов опухоли в легкие
Drozdovskiĭ et al. Radiosynoviorthese in the treatment of patients with rheumatoid arthritis
Guida et al. 41. Dose intercomparison at European hadrotherapy centers
Erb THE EQUIVALENT-RADIUS SCATTER-AIR RATIO MODEL FOR INHOMOGENEITY AND IRREGULAR FIELD CORRECTIONS IN RADIATION TELETHERAPY.
Maruyama et al. Radiosensitivity of C. parvum-stimulated spleen to acute 60Co and low dose rate 137Cs and 252Cf irradiation
Reves et al. Continuous infusion of intravenous anesthetics: Automated iv anesthesia, a rational method of drug administration
Chiba et al. Effect of Endotoxin on the SA Node in Situ in the Dog Heart
Ragelis Penicillin and streptomycin penetration into tissue by a modified electrophoretic method
Chen et al. CLINICAL PHVSICS FOR CHARGED PARTICLE RADIOTHERAPY

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0827411

Country of ref document: EP